Mubadala Investment Company’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.7M | Hold |
12,985,927
| – | – | 0.35% | 7 |
|
|
2025
Q1 | $68.7M | Hold |
12,985,927
| – | – | 0.39% | 6 |
|
|
2024
Q4 | $87.8M | Hold |
12,985,927
| – | – | 0.43% | 5 |
|
|
2024
Q3 | $85.6M | Hold |
12,985,927
| – | – | 0.45% | 4 |
|
|
2024
Q2 | $97.4M | Hold |
12,985,927
| – | – | 0.39% | 6 |
|
|
2024
Q1 | $129M | Hold |
12,985,927
| – | – | 0.51% | 5 |
|
|
2023
Q4 | $128M | Buy |
+12,985,927
| New | +$128M | 0.43% | 5 |
|